Myeloma chemotherapy with autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy25

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Bone Marrow Mesenchymal Stromal Cells Bone Marrow Cells Pluripotent Stem Cells T-Lymphocytes Neural Stem Cells Cells, Cultured Induced Pluripotent Stem Cells Multipotent Stem Cells Antilymphocyte Serum Plasma Cells Fetal Stem Cells Neoplastic Stem Cells Fetal Blood Spermatogonia Cell Line, Tumor Plant Stems Allografts Blood Cells Clone Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Mice, SCID Cytomegalovirus

Diseases52

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Leukemia, Myeloid, Acute Leukemia, Plasma Cell Lymphoma, B-Cell Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Neoplasms, Second Primary Neoplasm Recurrence, Local Leukemia, Myeloid Neutropenia Leukemia Acute Disease Neoplasms Disease Progression Precursor Cell Lymphoblastic Leukemia-Lymphoma Breast Neoplasms Hematologic Diseases Lymphoma, AIDS-Related Hepatic Veno-Occlusive Disease Neuroblastoma Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Mucositis Cytomegalovirus Infections Paraproteinemias Anemia, Aplastic Infection Medulloblastoma Chromosome Aberrations Severe Combined Immunodeficiency Thrombocytopenia Lymphoproliferative Disorders Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Central Nervous System Neoplasms Disease Models, Animal Postoperative Complications Blood Group Incompatibility Translocation, Genetic Bone Neoplasms

Chemicals and Drugs49

Melphalan Etoposide Cyclophosphamide Myeloablative Agonists Cytarabine Carmustine Thiotepa Vincristine Boronic Acids Pyrazines Doxorubicin Dexamethasone Busulfan Thalidomide Antineoplastic Agents, Alkylating Antibodies, Monoclonal, Murine-Derived Antigens, CD34 Antineoplastic Agents Ifosfamide Granulocyte Colony-Stimulating Factor Prednisone Podophyllotoxin Myeloma Proteins Mitoxantrone Idarubicin Cisplatin Carboplatin Immunosuppressive Agents Antibodies, Monoclonal Immunoglobulin Light Chains Keratins, Type II Vidarabine Bleomycin HLA Antigens Methotrexate Antilymphocyte Serum Immunoconjugates Stem Cell Factor Recombinant Proteins Cyclosporine Prednisolone Minor Histocompatibility Antigens Antigens, CD Immunologic Factors Antigens, CD20 Nitrogen Mustard Compounds Antibodies, Neoplasm Biological Markers Tacrolimus

Analytical, Diagnostic and Therapeutic Techniques and Equipment94

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Disease-Free Survival Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Prognosis Follow-Up Studies Liver Transplantation Induction Chemotherapy Mesenchymal Stem Cell Transplantation Leukapheresis Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Blood Component Removal Prospective Studies Chemotherapy, Adjuvant Histocompatibility Testing Feasibility Studies Drug Administration Schedule Fatal Outcome Life Tables Radioimmunotherapy Risk Factors Neoplasm Staging Heart Transplantation Immunotherapy Clinical Trials as Topic Lung Transplantation Kaplan-Meier Estimate Blood Transfusion, Autologous Flow Cytometry Organ Transplantation Transplantation, Isogeneic Lymphocyte Transfusion Treatment Failure Pilot Projects Immunosuppression Transplantation Islets of Langerhans Transplantation Positron-Emission Tomography Lymphocyte Depletion Cell Separation Immunophenotyping Predictive Value of Tests Randomized Controlled Trials as Topic Platelet Count Pancreas Transplantation Transplantation, Heterologous Multivariate Analysis Proportional Hazards Models Cell Culture Techniques Severity of Illness Index Immunomagnetic Separation Donor Selection Radiotherapy Leukocyte Count Stem Cell Research Drug Therapy Cohort Studies Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Disease Models, Animal Infusions, Intravenous Immunohistochemistry Colony-Forming Units Assay Actuarial Analysis Polymerase Chain Reaction Transplantation, Heterotopic Incidence Blood Cell Count Immunotherapy, Adoptive Neoadjuvant Therapy Coculture Techniques Lymphocyte Count Reverse Transcriptase Polymerase Chain Reaction Platelet Transfusion Cell Count

Psychiatry and Psychology1

Phenomena and Processes29

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Dose-Response Relationship, Drug Transplantation Immunology Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Cell Proliferation Cell Lineage Platelet Count Drug Resistance, Neoplasm Regeneration Chromosome Aberrations Immunocompromised Host Transplantation Tolerance Leukocyte Count Virus Activation Cell Survival Blood Cell Count Translocation, Genetic Lymphocyte Count Phenotype Apoptosis Cell Count

Disciplines and Occupations2

Stem Cell Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care25

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Clinical Trials as Topic Kaplan-Meier Estimate Treatment Failure Pilot Projects Predictive Value of Tests Randomized Controlled Trials as Topic Age Factors Multivariate Analysis Proportional Hazards Models Severity of Illness Index Donor Selection Cohort Studies Actuarial Analysis Incidence

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Multiple Myeloma Peripheral Blood Stem Cell Transplantation Melphalan Antineoplastic Combined Chemotherapy Protocols Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Stem Cells Disease-Free Survival Etoposide Cyclophosphamide Hodgkin Disease Myeloablative Agonists Lymphoma, Non-Hodgkin Recurrence Cytarabine Carmustine Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Graft vs Host Disease Thiotepa Vincristine Bone Marrow Purging Survival Analysis Hematologic Neoplasms Boronic Acids Pyrazines Lymphoma, Mantle-Cell Whole-Body Irradiation Amyloidosis Doxorubicin Retrospective Studies Dexamethasone Hematopoietic Stem Cells Busulfan Prognosis Thalidomide Graft Survival Antineoplastic Agents, Alkylating Antibodies, Monoclonal, Murine-Derived Follow-Up Studies Lymphoma, Follicular Antigens, CD34 Autografts Lymphoma, T-Cell, Peripheral Antineoplastic Agents Liver Transplantation Ifosfamide Induction Chemotherapy Time Factors Mesenchymal Stem Cell Transplantation Granulocyte Colony-Stimulating Factor Leukapheresis Prednisone Lymphoma Podophyllotoxin Maintenance Chemotherapy Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Transplantation Chimera Tissue Donors Leukemia, Myeloid, Acute Cord Blood Stem Cell Transplantation Leukemia, Plasma Cell Cell Transplantation Lymphoma, B-Cell Kidney Transplantation Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Myelodysplastic Syndromes Myeloma Proteins Mitoxantrone Idarubicin Neoplasms, Second Primary Infusions, Spinal Cisplatin Blood Component Removal Prospective Studies Carboplatin Adult Stem Cells Immunosuppressive Agents Antibodies, Monoclonal Chemotherapy, Adjuvant Histocompatibility Testing Neoplasm Recurrence, Local Feasibility Studies Drug Administration Schedule Bone Marrow Immunoglobulin Light Chains Fatal Outcome Leukemia, Myeloid Cell Differentiation Keratins, Type II

No FAQ available that match "myeloma chemotherapy with autologous stem cell transplantation"